Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 juin 2024 14h33 HE | Source: London Research and Pharmaceuticals

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

London Research & Pharmaceuticals Presents Advancement of LRP-661, Their Lead Drug Candidate, at the New Antiepileptic Drug Conference in Madrid, Spain
15 avr. 2024 08h00 HE | Source: London Research and Pharmaceuticals

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
03 juin 2019 10h26 HE | Source: Kentico

Kentico Evaluates the Business Benefits of Cloud-Hosted Web Content Management, Online Marketing, and E-commerce Capabilities

BEDFORD, N.H., June 03, 2019 (GLOBE NEWSWIRE) -- Today, Kentico Software, a leading provider of digital experience and content management solutions, released a new report which assesses the impact...